Xponance Inc. decreased its position in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 13.6% during the second quarter, HoldingsChannel.com reports. The firm owned 6,028 shares of the company’s stock after selling 945 shares during the quarter. Xponance Inc.’s holdings in Azenta were worth $317,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of AZTA. US Bancorp DE lifted its stake in Azenta by 3.8% during the 4th quarter. US Bancorp DE now owns 13,239 shares of the company’s stock valued at $862,000 after acquiring an additional 480 shares during the period. Schroder Investment Management Group lifted its stake in Azenta by 14.6% during the 4th quarter. Schroder Investment Management Group now owns 625,515 shares of the company’s stock valued at $40,746,000 after acquiring an additional 79,913 shares during the period. Lighthouse Investment Partners LLC bought a new position in Azenta during the 4th quarter valued at about $1,973,000. Neuberger Berman Group LLC lifted its stake in Azenta by 8.6% during the 4th quarter. Neuberger Berman Group LLC now owns 7,770 shares of the company’s stock valued at $506,000 after acquiring an additional 616 shares during the period. Finally, HighPoint Advisor Group LLC bought a new position in Azenta during the 4th quarter valued at about $364,000. Institutional investors own 99.08% of the company’s stock.
Analysts Set New Price Targets
Several research firms have issued reports on AZTA. Evercore ISI lowered their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday. Needham & Company LLC reiterated a “buy” rating and issued a $69.00 price objective on shares of Azenta in a research note on Wednesday, August 7th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Azenta has a consensus rating of “Hold” and a consensus target price of $66.40.
Azenta Stock Down 1.9 %
Shares of NASDAQ:AZTA opened at $47.50 on Wednesday. The firm’s 50 day moving average price is $51.37 and its 200-day moving average price is $53.11. The stock has a market capitalization of $2.56 billion, a PE ratio of -17.53 and a beta of 1.47. Azenta, Inc. has a twelve month low of $44.00 and a twelve month high of $69.16.
Azenta (NASDAQ:AZTA – Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.09. The company had revenue of $173.00 million during the quarter, compared to analyst estimates of $166.14 million. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The firm’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.13 EPS. Analysts expect that Azenta, Inc. will post 0.33 earnings per share for the current fiscal year.
Azenta Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Articles
- Five stocks we like better than Azenta
- Dividend Payout Ratio Calculator
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What to Know About Investing in Penny Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.